Dietary iron overload in the African and hepatocellular carcinoma

Liver International

Volumn 27, Issue 6, 2007, Pages 735-741

  Kew, Michael C ^a   Asare, George A ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

African Blacks; Cirrhosis; Dietary iron overload; DNA damage; Hepatocellular carcinoma; Hereditary haemochromatosis; Oxidative damage; Portal fibrosis

Indexed keywords

DNA; REACTIVE OXYGEN METABOLITE;

AFRICA; BEER; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; DISEASE ASSOCIATION; DISEASE MODEL; DNA DENATURATION; DNA REPAIR; DNA STRAND BREAKAGE; FOOD INTAKE; GENE MUTATION; GENETIC DISORDER; GENETIC PREDISPOSITION; HEMOCHROMATOSIS; HUMAN; IRON OVERLOAD; LIPID PEROXIDATION; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; MALIGNANT TRANSFORMATION; NONHUMAN; OXIDATIVE STRESS; REVIEW; TUMOR SUPPRESSOR GENE;

AFRICA SOUTH OF THE SAHARA; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; DNA DAMAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IRON OVERLOAD; IRON, DIETARY; LIPID PEROXIDATION; LIVER CIRRHOSIS; LIVER NEOPLASMS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RISK ASSESSMENT; RISK FACTORS;

EID: 34447316126     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2007.01515.x     Document Type: Review

References (88)

1. Strachan AS. Haemosiderosis and haemochromatosis in South African natives with a comment on the aetiology of haemochromatosis. MD Thesis: University of Glasgow, Glasgow, Scotland, 1929.
2. Walker ARP, Arvidsson UB. Iron overload in the South African Bantu. Tr Roy Soc Trop Med Hyg 1953; 47: 536-48.
3. Bothwell TH, Bradlow BA. Siderosis in the Bantu. A combined histopathological and chemical study. Arch Path 1960; 70: 279-92.
4. Bothwell TH, Seftel H, Jacobs P, Torrance JD, Baumslag N. Iron overload in Bantu subjects. Studies on the availability of iron in Bantu beer. Am J Clin Nutr 1964; 14: 47-51.
5. Gordeuk VR, Boyd RD, Brittenham GM. Dietary iron overload persists in rural sub-Saharan Africa. Lancet 1986; 1: 1310-3.
6. Gordeuk VR. African iron overload. Semin Hematol 2002; 39: 263-9.
7. Moyo VM, Gangaidzo IT, Gomo ZA, et al. Traditional beer consumption and the iron status of spouse pairs from a rural community in Zimbabwe. Blood 1997; 89: 2159-66.
8. MacPhail AP, Mandishona E, Bloom P, Paterson AC, Rouault TA, Gordeuk VR. Measurements of iron status and survival in African iron overload. S Afr Med J 1999; 89: 966-72.
9. Friedman BM, Baynes RD, Bothwell TH, et al. Dietary iron overload in southern African rural blacks. S Afr Med J 1990; 78: 301-5.
10. Bothwell TH, Isaacson C. Siderosis in the Bantu: A comparison of incidence in males and females. Br Med J 1962; 1: 522-4.
11. Chapman RW, Morgan MY, Laulicht M, Hoffbrand AV, Sherlock S. Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic haemochromatosis. Dig Dis Sci 1982; 27: 909-16.
12. MacPhail AP, Simon MO, Torrance JD, Charlton RW, Isaacson C, Bothwell TH. Changing patterns of dietary iron overload in black South Africans. Am J Clin Nutr 1979; 32: 1272-8.
13. Valberg LS, Simon JB, Manley PM, Corbett WE, Ludwig J. Distribution of storage iron as body stores expand in patients with haemochromatosis. J Lab Clin Med 1975; 86: 479-89.
14. Brink B, Disler P, Lynch SR, Jacobs P, Charlton RW, Bothwell TH. Patterns of iron storage in dietary iron overload and idiopathic haemochromatosis. J Lab Clin Med 1976; 88: 725-31.
15. Isaacson C, Seftel HC, Keeley KJ, Bothwell TH. Siderosis in the Bantu: the relationship between iron overload and cirrhosis. J Lab Clin Med 1961; 58: 845-53.
16. Gangaidzo IT, Moyo VM, Saungweme T, et al. High prevalence of iron overload in urban Africans in the 1990's. Gut 1999; 45: 278-83.
17. McNamara L, MacPhail AP, Mandishona E, et al. Non-transferrin bound iron and hepatic dysfunction in African dietary iron overload. J Gastroenterol Hepatol 1999; 14: 126-32.
18. Hershko C, Graham G, Bates TW, Rachmilewitz EA. Non-specific serum iron in thalassaemia. An abnormal serum iron fraction of potential toxicity. Br J G Haemat 1987; 40: 255-63.
19. Gutteridge JMC, Rowley DA, Griffiths E, Halliwell B. Low molecular weight iron complexes with oxygen radical reactions in inherited Haemochromatosis. Clin Sci 1985; 678: 463-7.
20. Gordeuk VR, Mukiibi J, Hassstedt SJ., et al. Iron overload in Africa: interaction between a gene and dietary iron content. N Engl J Med 1992; 326: 95-100.
21. Moyo VM, Mandishona V, Hasstedt SJ, et al. Evidence of genetic transmission in African iron overload. Blood 1998; 91: 1076-82.
22. McNamara L, MacPhail AP, Gordeuk VR, Hasstedt SJ, Rouault T. Is there a link between African iron overload and the described mutations of the hereditary haemochromatosis gene? Br J Haematol 1998; 102: 1176-8.
23. Beutler E, Barton JC, Felitti VJ, et al. Ferroportin (SLC40A1) variant associated with iron overload in African-Americans. Blood Cells Mol Dis 2003; 31: 305-9.
24. Gordeuk VR, Caleffi A, Coradini E, et al. Iron overload in Africans and African-Americans and a common mutation in the SCL40A19 Ferroportin gene. Blood Cells Mol Dis 2003; 31: 299-304.
25. McNamara L, Gordeuk VR, MacPhail AP. Ferroportin Q248H mutations in African families with dietary iron overload. J Gastroenterol Hepatol 2005; 20: 1855-8.
26. Seftel HC, Malkin C, Schaman A, et al. Osteoporosis, scurvy, and siderosis in Johannesburg Bantu. Br Med J 1966; 1: 642-6.
27. Seftel HC, Keely KJ, Isaacson C, Bothwell TH. Siderosis in the Bantu: the clinical incidence of haemochromatosis in diabetic subjects. J Lab Clin Med 1961; 58: 837-44.
28. Higginson J. Primary carcinoma of the liver in Africa. Br J Cancer 1956; 10: 609-22.
29. Higginson J. Pathogenesis of liver cancer in the Johannesburg area (S Africa). Acta-Unio Int Contra Cancrum 1957; 13: 590-8.
30. Higginson J. The geographic pathology of primary liver cancer. Cancer Res 1963; 23: 1624-33.
31. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HAJ, Stromeyer MD. Survival and causes of death in cirrhotic and non-cirrhotic patients with primary haemochromatosis. N Eng J Med 1985; 313: 11256-62.
32. Deugnier YM, Guyader D, Crantock L, et al. Primary liver cancer in genetic haemochromatosis: A clinical, pathological and pathogenetic study of 54 cases. Gastroenterology 1993; 104: 228-34.
33. Gangaidzo IT, Gordeuk VR. Hepatocellular carcinoma and African iron overload. Gut 1995; 37: 727-30.
34. Gordeuk VR, McLaren CE, MacPhail AP, Deichsel D, Bothwell TH. Associations of iron overload in Africa and hepatocellular carcinoma and tuberculosis. Blood 1996; 87: 3470-6.
35. Moyo VM, Makinuke R, Gangaudzo IT, et al. African iron overload and hepatocellular carcinoma. Eur J Haematol 1998; 60: 28-34.
36. Mandishoma E, MacPhail AP, Gordeuk VR, et al. Dietary iron overload as a risk factor for hepatocellular carcinoma in Black Africans. Hepatology 1998; 27: 1563-6.
37. Kew MC, Pooper H. Relationship between hepatocellular carcinoma and cirrhosis. Semin Liv Dis 1984; 4: 136-46.
38. Goh J, Callagy G, McEntee G, O'Keane JC, Bomford A, Crowe J. Hepatocellular carcinoma arising in a non-cirrhotic liver in genetic haemochromatosis: Three case reports and a review of the literature. Eur J Gastroenterol 1999; 11: 915-9.
39. Pelisse M, Gonzalez-Abraldes J, Navas M, Miquel B, Bruguera M. Hepatocellular carcinoma in a patient with hereditary haemochromatosis without cirrhosis. Gastroenterol Hepatol 2001; 234: 132-4.
40. Kohler HH, Hohler T, Kusel U, Kirkpatrick CJ, Schirmacher P. Hepatocellular carcinoma in a patient with hereditary haemochromatosis and non-cirrhotic liver. A case report. Pathol Res Pract 1999; 195: 509-13.
41. Britto MR, Thomas LA, Balaratnam N, Griffiths AP, Duane PD. Hepatocellular carcinoma arising in a non-cirrhotic liver in genetic haemochromatosis. Scand J Gastroenterol 2000; 35: 889-93.
42. Brage A, Tome S, Figueruela B, Abdulkader I, Martinez J, Varo E. Hepatoma in a 40 year old male with hereditary hemochromatosis in the absence of cirrhosis. Res Esp Enferm Dig 2002; 94 (8): 493-9.
43. Hepatoma in a 40-year old male with hereditary haemochromatosis in the absence of cirrhosis: Implications of molecular diagnosis. Rev Esp Enferm Org 2002; 94: 493-9.
44. von Delius S, Lersch C, Schulte-Frohlinde E, et al. Hepatocellular carcinoma associated with hereditary hemochromatosis occurring in non-cirrhotic liver. Z Gastroenterol 2006; 44: 39-42.
45. Bradbear RA, Bain C, Siskind V, et al. Cohort study of internal malignancy in genetic haemochromatosis and other chronic non-alcoholic liver diseases. J Natl Cancer Inst 1985; 75: 81-4.
46. Francanzani AL, Conte D, Fraquelli M, et al. Increased cancer risk in a cohort of 230 patients with hereditary haemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease. Hepatology 2001; 33: 647-65.
47. Fargion S, Mandelli C, Piperno A, et al. Survival and prognostic factors in 212 Italian patients with genetic haemochromatosis. Hepatology 1992; 15: 655-9.
48. Barry M, Tavill AS, Brittenham GM, Park CH, Ross CF, Williams R. Hereditary spherocytosis with secondary haemochromatosis. Lancet 1968; 2: 481-5.
49. Chung H, Kudo M, Kawasaki T, et al. Hepatocellular carcinomas associated with secondary haemochromatosis in a non-cirrhotic liver: A case report. Hepatol Res 2003; 26: 254-8.
50. Borgna-Pignatti C, Vergine G, Lombardo T, et al. Hepatocellular carcinoma in the thalassaemia syndromes. Br J Haematol 2004; 124: 114-7.
51. Gonzales J, Benirchke K, Saltman P, Roberts J, Robinson P. Haemosiderosis in lemurs. Zoo Biol 1984; 3: 255-65.
52. Randel MG, Patnaik AK, Gould WJ. Hepatopathy associated with excessive iron storage in Mynah birds. J Am Vet Med Assoc 1981; 179: 1214-7.
53. Kato J, Kobune Y, Kohgo Y, et al. Hepatic iron deprivation prevents spontaneous development of fulminant hepatitis and liver cancer in long-evans cinnamon rats. J Clin Invest 1996; 98: 923-9.
54. Park CH, Bacon BR, Brittenham GM, Tavill AS. Pathology of dietary carbonyl iron overload in rats. Lab Invest 1987; 57: 555-63.
55. Iancu TC, Ward RJ, Peters TJ. Ultrastructural observation in the carbonyl iron fed rat: An animal model for haemochromatosis. Virchows Archives B 1987; 53: 208-17.
56. Ward RJ, Florence AL, Baldwin D, et al. Biochemical and biophysical investigations of the ferrocene iron-loaded rat. An animal model of primary haemochromatosis. Eur J Biochem 1991; 202: 405-10.
57. Dullman J, Wulfhekel U, Nielsen P, Heinrich HC. Iron overload of the liver by trimethyl hexanoyl ferrocene in rats. Acta Anat 1992; 43: 96-108.
58. Nielsen P, Heinrich HC. Metabolism of iron from (3,3,5-trimethyl hexanoyl) ferrocene in rats. Biochem Pharmacol 1993; 45: 385-91.
59. Asare GA, Paterson AC, Kew MC, Khan S, Mossanda KS. Iron-free neoplastic nodules and hepatocellular carcinoma without cirrhosis in wistar rats fed a diet high in iron. J Pathol 2006; 208: 82-90.
60. Deugnier YM, Charambalous P, Le Quilleuc D, et al. Preneoplastic significance of hepatic iron-free foci in genetic haemochromatosis: A study of 85 patients. Hepatology 1993; 18: 1363-9.
61. Tatematsu M, Tsuda H, Shirai T, Matsui T, Ito N. Placental glutathione S transferase as a new marker for hepatocarcinogenesis: In vivo short-term screening for hepatocarcinogenesis. Toxicol Pathol 1986; 15: 60-8.
62. Libbrecht L, Desmet V, Roskams T. Preneoplastic lesions in human hepatocarcinogenesis. Liver Int 2005; 25: 16-27.
63. Hagen TM, Huang S, Curnutte J, et al. Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc Natl Acd Sci USA 1994; 91: 12808-12.
64. Jungst C, Cheng B, Gehrke R, et al. Oxidative damage is increased in human liver tissue adjacent to hepatocellular carcinoma. Hepatology 2004; 39: 1663-72.
65. Asare GA, Mossanda KS, Kew MC, Paterson AC, Kahler-Venter CP, Siziba K. Hepatocellular carcinoma caused by iron overload: A possible mechanism of direct hepatocarcinogenicity. Toxicology 2006; 219: 41-52.
66. Benhar M, Engelberg D, Levitzki A. Reactive oxygen stress, stress-activated kinases and stress signalling in cancer. EMBO Rep 2002; 3: 420-5.
67. Thirunavukkarasu C, Sakthisekaran D. Effect of selenium on N-nitrodiethylamine induced multistage hepatocarcinogenesis with reference to lipid peroxidation and enzymatic antioxidants. Cell Biol Funct 2001; 19 (1): 27-35.
68. Sakar A, Bishauyee A, Chatterjee M. Beta-carotene prevents lipid peroxidation and red blood cell membrane protein damage in experimental hepatocarcinogenesis. Cancer Biochem Biophys 1995; 15 (2): 111-25.
69. Kalender Y, Yel M, Kalender S. Doxorubicin hepatotoxicity and hepatic free radical metabolism in rats, the effects of vitamin E and catechin. Toxicology 2005; 209: 39-45.
70. Esterbauer H, Eckl P, Ortner A. Possible mutagens derived from lipids and lipid precursors. Mutat Res 1990; 238 (3): 223-33.
71. West JD, Marnett LJ. Alterations in gene expression induced by the lipid peroxidation product 4-hydroxy-2-nonenal. Chem Res Toxicol 2005; 18 (11): 1642-53.
72. Chauhan A, Chauhan VW, Brown T, Cohen I. Oxidative stress: In autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin - the antioxidant protein. Life Sci 2004; 75: 2539-49.
73. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radic Biol Med 1991; 11 (1): 81-128.
74. Esterbauer H. Cytotoxicity and genotoxicity of lipid-oxidation products. Am J Clin Nutr 1993; 57 (suppl): 779-86S.
75. Wacker M, Wanek P, Eder E. Detection of 1, N 2-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal after gavage of trans-4-hydroxy-2-nonenal or induction of lipid peroxidation with carbon tetrachloride in F344 rats. Chem Biol Interact 2001; 137 (3): 269-83.
76. Chung F-L, Nath RG, Ocando J, Nishikawa A, Zhang L. Deoxyguanosine adducts of t-4-hydroxy-2-nonenal are endogenous DNA lesions in rodents and humans: Detection and potential sources. Cancer Res 2000; 60: 1507-11.
77. Kasai H, Chung HM, Jones DS, et al. 8-Hydroxydeoxyguanosine, a DNA adduct formed by oxygen radicals: Its implication on oxygen radical-involved mutagenesis/carcinogenesis. J Toxicol Sci 1991; 16 (Suppl. 1): 95-105.
78. Kuchino Y, Mori F, Kasai H, Inoue H, Iwai S, Miura K. Misreading of DNA templates containing 8-hydroxydeoxguanosine at the modifies base and at adjacent residues. Nature 1989 7-13 327 (6117): 77-79.
79. Orimo H, Toura Y, Hino R, Kasai H. Formation of 8-hydroxy-2′-deoxyguanosine in the DNA of cultured keratinocytes by clinically used doses of narrowband and broadband B and psoralen plus ultraviolet light. Cancer Sci 2006; 97: 99-105.
80. Cheng KC, Cahill DS, Kasai H, Nishimura S, Loeb LA. 8-hydroxylguanine, an abundant form of oxidative DNA damage causes G-T and A-C substitutions. J Biol Chem 1992; 267: 166-72.
81. Ichiba M, Maeta Y, Mukoyama T, et al. Expression of 8-hydroxy-2′-deoxyguanosine in chronic liver disease and hepatocellular carcinoma. Liver Int 2003; 23: 1781-9.
82. Cheeseman KH. Lipid peroxidation in cancer. In: Halliwell B, Arouma AI, eds. DNA and Free Radicals. London: Ellis Horwood, 1993; 109-44.
83. Hussain SP, Raja K, Amstad PA, et al. Increased p53 mutation load in non-tumorous human liver of Wilson disease and haemochromatosis: oxyradical overload disease. Proc Natl Acad Sci USA 2000; 97: 12770-5.
84. Marrogi AJ, Khan MA, van Gijssel HE, et al. Oxidative stress and p53 mutations in the carcinogenesis of iron-overload-associated hepatocellular carcinoma. J Natl Cancer Inst 2001; 93: 1652-5.
85. Troadec M-B, Courselaud B, Detwaud L, et al. Iron overload promotes cyclinD1 expression and alters cell cycle in mouse hepatocytes. J Hepatol 2006; 44: 391-9.
86. 1 and hepatitis B virus in hepatocarcinogenesis. Liver Int 2003; 23: 1-5.
87. 1 and dietary iron overload in hepatic mutagenesis. Toxicology (in press).
88. Marrogi AJ, Khan MA, Van Gijssel HE, et al. Oxidative stress and p53 mutations in the carcinogenesis of iron-overload associated hepatocellular carcinoma. J Natl Cancer Inst 2001; 93: 1652-5.